#Softgel Capsules Market Research

[adhk1234]

Omega 3 Supplements Market Industry Overview: Present Status and Growth Prospects

The global omega-3 supplements market is experiencing significant growth, driven by increasing consumer awareness of the health benefits associated with omega-3 fatty acids. Valued at USD 8.00 billion in 2023, the market is projected to reach USD 17.12 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.83% over the forecast period of 2024-2032.

Market Segmentation:

The omega-3 supplements market is segmented based on source, form, functionality, and end-user:

By Source:

Fish Oil

Krill Oil

Algae Oil

By Form:

Tablets

Capsules

Soft Gels

By Functionality:

Cardiovascular Health

Brain, Nervous System & Mental Health

Eye Diseases

Diabetes

By End-User:

Adults

Children

Pregnant Women

Elderly

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1067

Regional Analysis:

North America currently leads the omega-3 supplements market, attributed to high consumer awareness and a strong focus on preventive healthcare. Europe follows, with significant demand driven by health-conscious consumers. The Asia-Pacific region is anticipated to witness the fastest growth during the forecast period, owing to rising disposable incomes and increasing health awareness among the population.

Key Players

Nordic Naturals, Inc.

Omega-3 Fish Oil Supplements

Ultimate Omega (Fish Oil)

Omega-3 Pet Supplements

DHA 500mg (Fish Oil)

NutriGold Inc.

Omega-3 Gold (Fish Oil)

Omega-3 Vegan DHA

Omega-3 Gold with EPA

Reckitt Benckiser Group plc

Nutri-Health Omega-3 Fish Oil Supplements

Mucinex Omega-3 Fish Oil

Pharma Nord B.V.

BioActive Omega-3

Omega-3 Krill Oil

Omega-3 Softgels

i-Health, Inc.

Omega-3 Adult Gummies (Fish Oil)

Omega-3 Kids Gummies

Aker BioMarine AS

Superba Krill Oil

Omega-3 Phospholipid Oil

Luhua Biomarine (Shandong) Co., Ltd.

Omega-3 Fish Oil Concentrates

Omega-3 EPA/DHA

Pharmavite LLC

Nature Made Fish Oil Softgels

Omega-3 1200mg Softgels

KD Pharma Group

Omega-3 Fish Oil Concentrates

Omega-3 70% EPA/DHA

NOW Foods

Omega-3 Fish Oil Softgels

Omega-3 DHA & EPA Softgels

Omega-3 1000mg Softgels

GlaxoSmithKline plc

Sensodyne Omega-3 Fish Oil Supplements

Omega-3 Fish Oil for Heart Health

Natrol LLC

Omega-3 Fish Oil Softgels

Omega-3 EPA/DHA 1000mg Softgels

Carlson Laboratories

Carlson Fish Oil

Carlson Super Omega-3 Softgels

OmegaBrite

OmegaBrite Omega-3 Fish Oil Supplements

OmegaBrite Plus Omega-3

Optimum Nutrition, Inc.

Fish Oil Softgels

Omega-3 EPA/DHA Softgels

VAYA Pharma

Omega-3 Fish Oil for Brain Health

Vaya Omega-3 Supplements

Vital Choice Wild Seafood & Organics, SPC

Omega-3 Wild Fish Oil

Omega-3 DHA Supplements

Bionova

Omega-3 Fish Oil Concentrates

Omega-3 DHA & EPA Softgels

The Nature’s Bounty Co.

Omega-3 Fish Oil Softgels

Omega-3 Gummies

Arkopharma

Arkocaps Omega-3 Capsules

Arkopharma Omega-3 Fish Oil Softgels

Key Highlights:

Growing consumer awareness of the health benefits of omega-3 fatty acids is a primary market driver.

Innovations in product formulations, such as plant-based and flavored supplements, are attracting a broader consumer base.

The cardiovascular health segment holds a significant share due to the proven benefits of omega-3s in heart health.

The Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period.

Future Outlook:

The omega-3 supplements market is poised for substantial growth, driven by ongoing research supporting the health benefits of omega-3 fatty acids and a global shift towards preventive healthcare. Innovations in supplement formulations, including plant-based sources and enhanced delivery methods, are expected to further propel market expansion. As consumer awareness continues to rise, the demand for omega-3 supplements is anticipated to increase across various demographics and regions.

Conclusion:

The global omega-3 supplements market is on a robust growth trajectory, with significant opportunities for stakeholders, including manufacturers, healthcare providers, and investors. The increasing emphasis on health and wellness, coupled with product innovations, positions the market for continued expansion in the coming years.

Contact Us: Jagney Dave - Vice President of Client Engagement Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Other Related Reports:

Medical Display Market Size

Medical Waste Containers Market Size

IoT Medical Devices Market Size

[industrynewsupdates]

Future of Probiotics Dietary Supplements Market: Insights from Industry Experts

The global probiotics dietary supplements market size is expected to reach USD 51.84 billion by 2030, registering a CAGR of 14.1% over the forecast periods, according to a new report by Grand View Research, Inc. Probiotic dietary supplements have become increasingly popular in recent years, driven by a number of factors. The growing awareness of the importance of gut health and its impact on overall health and well-being. Many consumers are turning to probiotics as a way to support their digestive health, boost their immune system, and improve their mood.

In addition, the incidence of digestive disorders is on the rise, leading to increasing demand for probiotic products. Probiotics combat harmful bacteria in the gut and are effective in treating conditions such as intestinal inflammation, antibiotic-associated diarrhea, and urogenital infections. With the growing awareness of preventative healthcare, the global probiotic market is expected to expand. Probiotics promote gut health and boost immunity, and yogurt is a commonly consumed source of these beneficial microorganisms.

Probiotic dietary supplements have gained popularity due to their convenience and the variety of appealing flavors such as apple, orange, and raspberry. These supplements contain lactic acid bacteria, particularly Streptococcus thermophilus and Lactobacillus, which regulate the digestive system and enhance immune responses. Lactobacillus is also effective in treating various conditions such as diarrhea, high cholesterol, skin disorders, irritable bowel syndrome, and lung infections.

Gather more insights about the market drivers, restrains and growth of the Probiotics Dietary Supplements Market

Probiotics Dietary Supplements Market Report Highlights

• The tablets & softgels form led the market in terms of revenue, with a share of over 40% in 2022. Tablets offer convenience, making them an ideal option for individuals with busy lifestyles. In addition, the robust presence of gelatin production units, along with the increasing demand for nutraceutical products, is expected to provide new opportunities for manufacturers of softgel probiotic dietary supplements globally

• Infants is expected to be the fastest-growing among the end-use segments, owing to the growing demand for personalized products that cater to the unique metabolic and intestinal requirements of infants. The infants segment is projected to expand at a CAGR of over 18% during the forecast period

• Probiotics are also beneficial for improving sleep quality by reducing inflammation and oxidative stress in the body, as well as by increasing the production of melatonin, a hormone that regulates sleep. In addition, supplements for sexual wellness are also available, which contain probiotics to support healthy vaginal or urinary tract flora

Probiotics Dietary Supplements Market Segmentation

Grand View Research has segmented the global probiotics dietary supplements market based on form, end-use, application and region:

Probiotics Dietary Supplements Form Outlook (Revenue, USD Million, 2017 - 2030)

• Chewables & Gummies

• Capsules

• Powders

• Tablets & Softgels

• Others

Probiotics Dietary Supplements End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Infants

• Children

• Adults

• Geriatric

Probiotics Dietary Supplements Applications Outlook (Revenue, USD Million, 2017 - 2030)

• Sports Fitness

• Energy & Weight Management

• General Health

• Bone & Joint Health

• Gastrointestinal Health

• Immunity

• Cardiac Health

• Diabetes

• Anti-cancer

• Skin/Hair/Nails

• Brain/Mental Health

• Others

Probiotics Dietary Supplements Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o UK

o Germany

o France

o Spain

o Italy

• Asia Pacific

o China

o India

o Japan

o Australia

o South Korea

• Central & South America

o Brazil

o Argentina

o Colombia

• Middle East & Africa

o South Africa

o UAE

o Saudi Arabia

Order a free sample PDF of the Probiotics Dietary Supplements Market Intelligence Study, published by Grand View Research.

[global-research-report]

Enhancing Lives: Strategic Insights into the Vitamin Supplements Industry

The global vitamin supplements market size is expected to reach USD 84.95 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 7.3% from 2023 to 2030. The market for vitamin supplements is mostly driven by rising consumer knowledge of nutrition, health, and well-being. The market is anticipated to grow as a result of increased consumer awareness of the nutritional advantages of dietary supplements, including vitamin supplements, due to campaigns launched by non-governmental organizations, governmental bodies, and companies.

Recent product introductions by big and small businesses have included organic and natural components, which has increased demand for vitamin supplements. In addition, the utilization of appealing packaging techniques has raised consumer awareness, which has, in turn, encouraged the purchase of such supplements. Consumers are more concerned about their health and favor goods that use less synthetic chemicals. Another significant element driving the demand for vitamin supplements is consumers' growing preference for nutritious foods and their willingness to spend more for them, particularly when purchasing goods like gummies and candies for kids.

Based on type, the multivitamin supplements segment led the market in 2022 and is expected to witness progressive growth during the forecast period. Multifunctionality is a crucial trend in the supplements market, exemplified by companies such as Blackmores, Vemedia Pharma, Nature Made, Dompé, Ritual, and Holland & Barrett. Multifunctional products offered by these companies are centered on a holistic approach to health and address various aspects of well-being simultaneously. This comprehensive approach appeals to consumers seeking a one-stop solution to their health needs, further boosting the demand for multivitamins.

Vitamin Supplements Market Report Highlights

Based on region, Asia Pacific is expected to grow with the fastest CAGR over the forecast period from 2023 to 2030. The increasing awareness regarding the health benefits of vitamin supplements in the region is a key factor surging the market growth

Based on form, the gummies segment is estimated to grow with the fastest CAGR over the forecast period. The increasing popularity of gummies vitamin supplements is fueling market growth

Based on distribution channel, the online segment is expected to grow with a faster CAGR over the forecast period from 2023 to 2030. The high convenience provided by the online channels is anticipated to contribute to the growth of the segment

Vitamin Supplements Market Segmentation

Grand View Research has segmented the global vitamin supplements market based on type, form, distribution channel, and region:

Vitamin Supplements Type Outlook (Revenue, USD Billion, 2017 - 2030)

Multivitamin

Vitamin A

Vitamin B

Vitamin C

Vitamin D

Vitamin E

Vitamin K

Vitamin Supplements Form Outlook (Revenue, USD Billion, 2017 - 2030)

Powder

Tablets

Capsules

Softgels

Gummies

Others

Vitamin Supplements Distribution Channel Outlook (Revenue, USD Billion, 2017 - 2030)

Offline

Pharmacies & Drugstores

Hypermarkets/Supermarkets

Others

Online

Vitamin Supplements Regional Outlook (Revenue, USD Billion, 2017 - 2030)

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Asia Pacific

China

Japan

India

South Korea

Australia & New Zealand

Central & South America

Brazil

Chile

Middle East & Africa

South Africa

UAE

List of Key Players

Glanbia plc

Pfizer Inc.

Bayer AG

Amway Corp.

GlaxoSmithKline plc.

Good Health New Zealand

The Nature's Bounty Co.

NOW Foods

Abbott

Herbalife Nutrition

Nature's Sunshine Products, Inc.

NU SKIN

RBK Nutraceuticals Pty Ltd.

American Health, Inc.

Pharmavite

Order a free sample PDF of the Vitamin Supplements Market Intelligence Study, published by Grand View Research.

[lifecarenutritions]

Which of the Leading Pharmaceutical Exporter from India

In this modern era, The demand of quality based product is rising day by day. So Many pharma companies in India is available for manufacturing, supply and export the pharma products. Lifecare Nutrition is a Best Pharma Export Company in India that has made its reputation in the world with the help of its high quality products. This company has established themselves as the Best Pharma Exporter in India, in their work tenure of 27+ years. 

At present, we have many clients around the globe and our plant facilities are accepted by countries like Bhutan, Yemen, Cambodia, Nepal, Burkina, Kenya, Oman, Ghana, Ukraine, Uzbekistan, Afghanistan, Myanmar, Iraq, UAE, Sudan, Zimbabwe, etc. As a pharmaceutical firm, we are well aware of the negative effects from chemical therapies. So, we feel proud of providing healthcare medicines in large amounts hoping to introduce our top-quality medicines to international markets with the vision of serving people. 

Lifecare Nutrition is an ISO Certified Nutraceutical Manufacturer in India which provides opportunities for high growth in the market dealing with all kinds of pharma products which are manufactured under the norms of WHO-GMP in order to match the global standards of the medicines. All the products manufactured are approved under FSSAI & DCGI at an affordable price. We manufacture products like capsules, tablets, syrups, injectables, suspension powder, etc. Apart from this, we provide hassle-free services that are contributed by customer care services and many more.

Preferring Pharmaceutical Company's is the best choice for export in India

India is the 3rd largest pharmaceutical ecosystem in terms of volume & 13th largest in terms of value. Today, India supplies 20%-22% of the world's exports of pharma products, making it the top provider in the world. With the passage of time, it has developed into the centre for global research and production. Our firm always serves with quality products in global markets and being a top Softgel Manufacturer in India we deal with a wide range of products that includes cardiac, neuro, diabetic, nutra.

Due to our efficient workers, people prefer to import services of pharma for their country.

Day by bay the top pharma products exporting company is witnessing the increasing orders for our pharma products. Due to extensive supply of raw materials & attainability of qualified & experienced staff, our affirm enjoys a competitive advantage as a pharmaceutical exporter of India. If you choose us to export pharma medicines from India, you won't be disappointed because of many reasons as discussed below:

For the manufacturing of the products we use advanced technology machineries for the better quality of the products.

We give our clients much support by dealing with transparency as it attracts them more and more to get our services.

We deal with 400 products making us a strong competitor in the market.

Our R&D brings the latest updates to our clients.

All the machines are well lubricated and serviced on a daily basis for better  performance.

More than 20 countries are importing the pharma products from our firm.

We provide lower manufacturing costs in the world while maintaining the high quality products.

Manufacturing costs can be reduced by machinery of affordable international grade.

We keep the highly demanded products in our stock to avoid any delay in delivery.

Cutting edge technology is being utilised by our firm.

Advantages of starting a partnership for export with the best pharmaceutical company in India

The research and development team works on various substances for bringing the updated pharma medicines to the market. We being the top pharma export company in India believes in winning the people's trust which will prove to high returns in the market and that is the real marketing tool for marketing. We bring the updated products to the market after introducing them to the associates. We highly focus on dealing with genuine products which are always inspected by our experts. Multiple selection of products helps our clients to make a strong position in the market.

 To obtain the profitable and quality of products, the supply chain handles the whole process from sourcing raw materials from reputable firms through manufacturing and then exporting  which ensures efficiency, less cost & other operations work easily throughout the whole chain. This reduces the raw materials as well as labour being used during the production process, making the product cost effective. Before the products are sent to the packaging team and quality control team conscientiously checks them. The best pharma products are forwarded in the production line for exporting and monitored by professional workers. Lastly, we believe that high quality medicines are the main reason behind companies choosing us and we are receiving more requests from other countries for exporting pharma products.

Basic requirements for exporting pharmaceutical products from India

Both the importer & supplier agree mutually on the terms and conditions of the export sale prior to the actual shipment of export. Delivery duration, method of transport, pricing, quality criteria, payment terms & so on are agreed upon with detail in the purchase order when exporting pharma products in India. Here are some of the requirements needed for exporting process:

Medicine original certificate

Documentation from shipment or carrier paperwork

Entry paperwork

Certificate of incorporation

Commercial invoice

Premises ownership proof

[latestmarketresearchnews]

Astaxanthin Market Size & Share | Statistics Report 2030

The global astaxanthin market reached a valuation of USD 2.34 billion in 2023, with projections indicating a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is driven by a rising demand for astaxanthin across various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages. Astaxanthin’s role in aquaculture is significant, where it is commonly used to enhance the coloration of species such as prawns, salmon, trout, and ornamental fish, increasing their market value. Additionally, astaxanthin offers numerous health benefits to aquatic animals, improving stress tolerance, performance, immune-related gene expression, reproductive capacity, survival rates, and disease resistance. To meet the rising demand in aquaculture, major industry players are focusing on product development and collaborative agreements.

Market growth is further supported by organizations that actively promote awareness of astaxanthin's diverse applications. For example, the Natural Algae Astaxanthin Association (NAXA) is influential in promoting, protecting, and educating the public on the benefits of natural astaxanthin across various industries. NAXA also supports relevant research and offers the NAXA Verification Seal to certify natural astaxanthin products.

To increase the penetration of natural astaxanthin-based products, companies are engaging in strategies such as new product launches and partnerships with influential players in related industries. For instance, Algalif partnered with Divi’s Nutraceuticals in May 2022 to release high-concentration astaxanthin beadlets called AstaBeads, targeting sports nutrition and healthy aging markets. Similarly, The Lubrizol Corporation launched ASTAGILE microcapsules in October 2020, focusing on enhancing cognitive and mental agility for both young and senior adults.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

The astaxanthin market showcases a high degree of innovation, with companies developing novel formulations and sustainable production methods. For example, Sirio Europe (SIRIO) revealed in August, 2023, its plan to introduce two new softgel products targeting the pharmaceutical sector during the CPHI Barcelona 2023 event.

The astaxanthin market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players In January 2022, ENEOS Corporation disclosed its acquisition of Ecocert Inputs Attestation, a globally recognized certification organization. This strategic move strengthens ENEOS' position in the astaxanthin market, particularly for Panaferd-AX. The merger reflects the company's commitment to quality and international standards, contributing to the evolution of the industry.

Product Segmentation Insights:

In 2023, dried algae meal or biomass dominated the market with a share of 25.26%. This significant share is attributed to its applications in biomass production for other forms, such as capsules and tablets, minimal downstream processing, convenient bulk production, and a higher demand for use as animal feed. New product launches in the sector, such as Solabia-Algatech Nutrition Ltd’s AstaPure Arava gummies in October 2022, highlight the growing demand for algal astaxanthin. Additionally, in May 2022, Algalif collaborated with start-up company Marea to create a biodegradable coating using residual algae biomass. These advancements are anticipated to support growth in this segment over the forecast period.

The softgel segment is expected to experience strong growth in the coming years, as softgels are widely favored by consumers for their convenience and suitability for the geriatric population. Veggie softgels, derived from modified cornstarch and glycerin, are particularly popular among nutraceutical companies due to their plant-based origin and minimal side effects. Regulatory approvals are further boosting this segment; for example, in September 2021, NextFerm Technologies obtained regulatory approval in the U.S. to market Astaferm, an innovative antioxidant in oil form for softgels.

These factors collectively contribute to the expansion of the global astaxanthin market across various segments and applications.

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[researchreportinsight]

Astaxanthin Market – Industry Trends and Forecast Report 2030

The global astaxanthin market reached a valuation of USD 2.34 billion in 2023, with projections indicating a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is driven by a rising demand for astaxanthin across various industries, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages. Astaxanthin’s role in aquaculture is significant, where it is commonly used to enhance the coloration of species such as prawns, salmon, trout, and ornamental fish, increasing their market value. Additionally, astaxanthin offers numerous health benefits to aquatic animals, improving stress tolerance, performance, immune-related gene expression, reproductive capacity, survival rates, and disease resistance. To meet the rising demand in aquaculture, major industry players are focusing on product development and collaborative agreements.

Market growth is further supported by organizations that actively promote awareness of astaxanthin's diverse applications. For example, the Natural Algae Astaxanthin Association (NAXA) is influential in promoting, protecting, and educating the public on the benefits of natural astaxanthin across various industries. NAXA also supports relevant research and offers the NAXA Verification Seal to certify natural astaxanthin products.

To increase the penetration of natural astaxanthin-based products, companies are engaging in strategies such as new product launches and partnerships with influential players in related industries. For instance, Algalif partnered with Divi’s Nutraceuticals in May 2022 to release high-concentration astaxanthin beadlets called AstaBeads, targeting sports nutrition and healthy aging markets. Similarly, The Lubrizol Corporation launched ASTAGILE microcapsules in October 2020, focusing on enhancing cognitive and mental agility for both young and senior adults.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market

The astaxanthin market showcases a high degree of innovation, with companies developing novel formulations and sustainable production methods. For example, Sirio Europe (SIRIO) revealed in August, 2023, its plan to introduce two new softgel products targeting the pharmaceutical sector during the CPHI Barcelona 2023 event.

The astaxanthin market is also characterized by a high level of merger and acquisition (M&A) activity by the leading players In January 2022, ENEOS Corporation disclosed its acquisition of Ecocert Inputs Attestation, a globally recognized certification organization. This strategic move strengthens ENEOS' position in the astaxanthin market, particularly for Panaferd-AX. The merger reflects the company's commitment to quality and international standards, contributing to the evolution of the industry.

Product Segmentation Insights:

In 2023, dried algae meal or biomass dominated the market with a share of 25.26%. This significant share is attributed to its applications in biomass production for other forms, such as capsules and tablets, minimal downstream processing, convenient bulk production, and a higher demand for use as animal feed. New product launches in the sector, such as Solabia-Algatech Nutrition Ltd’s AstaPure Arava gummies in October 2022, highlight the growing demand for algal astaxanthin. Additionally, in May 2022, Algalif collaborated with start-up company Marea to create a biodegradable coating using residual algae biomass. These advancements are anticipated to support growth in this segment over the forecast period.

The softgel segment is expected to experience strong growth in the coming years, as softgels are widely favored by consumers for their convenience and suitability for the geriatric population. Veggie softgels, derived from modified cornstarch and glycerin, are particularly popular among nutraceutical companies due to their plant-based origin and minimal side effects. Regulatory approvals are further boosting this segment; for example, in September 2021, NextFerm Technologies obtained regulatory approval in the U.S. to market Astaferm, an innovative antioxidant in oil form for softgels.

These factors collectively contribute to the expansion of the global astaxanthin market across various segments and applications.

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.

[unibiotech-formulations]

Why is Maintaining High Quality Standards Important For Unibiotech?

Unibiotech Formulation stands out from other pharma franchise companies in several ways! We have established ourselves as a trusted and reliable partner for healthcare professionals and patients alike with over 30 years of extensive experience in the pharmaceutical industry in terms of pharma franchise services. We offer a diverse range of pharmaceutical products, including softgel capsules, injectables, tablets, syrups, and ointments, across various therapeutic areas. This wide spectrum of offerings allows us to cater to diverse medical needs. We have dedicated ourselves to maintain high-quality standards in our manufacturing processes. All our products are tested and prepared according to WHO, GMP, and other regulatory guidelines, ensuring the highest level of safety and productivity. The company places a strong emphasis on research and development, allowing it to continuously deliver cutting-edge treatments and stay ahead of the curve in the competitive pharma market.

We offer a unique monopoly pharma franchise opportunity, providing partners with untouched PAN India locations and the ability to run their own businesses with lower overhead costs. This company provides its franchise partners with extensive marketing support, free promotional items, and on-time delivery to help them succeed in the competitive pharma industry.We always value integrity, transparency, and respect in their business dealings, ensuring that their partners and customers can trust in their commitment to improving healthcare outcomes for the masses.

[industryforecastnews]

Vegan Omega-3 Supplements Market To Reach USD 2.98 Billion By 2030

 Vegan Omega-3 Supplements Market Growth & Trends

The global vegan omega-3 supplements market is expected to reach USD 2.98 billion by 2030, growing at a CAGR of 9.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is mainly driven by driven by a confluence of health, environmental, and ethical factors. One of the primary drivers is the increasing awareness of the health benefits associated with omega-3 fatty acids, which include improved cardiovascular health, enhanced cognitive function, and anti-inflammatory properties.

Consumers are becoming more health-conscious and are actively seeking plant-based alternatives to traditional fish oil supplements. For example, algae-based omega-3 supplements are gaining popularity as they provide a sustainable and vegan-friendly source of essential fatty acids, particularly EPA and DHA. Environmental concerns also play a crucial role; overfishing and the ecological impact of fish oil production have prompted a shift towards more sustainable sources.

The appeal of vegan omega-3 supplements is further enhanced by the introduction of innovative delivery systems, such as pectin-based softgels. These advancements address concerns regarding gelatin-derived capsules and provide a more attractive option for consumers seeking vegan-friendly supplements. As the market evolves, manufacturers and suppliers have the opportunity to capitalize on the growing demand by offering high-quality, sustainable, and effective vegan omega-3 supplements to meet the needs of a diverse consumer base.

The competitive landscape of the vegan omega-3 supplement market is characterized by a mix of established nutraceutical companies and emerging startups, all vying for a share of this rapidly growing segment. Major players like Barlean's Organic Liquid, LLC, i-Health, Inc., Source Naturals, Inc., NUTRU, Nordic Naturals, Calgee, and NOW Foods,  have established a strong presence by leveraging their expertise in plant-based formulations and sustainable sourcing.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/vegan-omega-3-supplements-market-report

Vegan Omega-3 Supplements Market Report Highlights

Algae-based vegan omega-3 supplements held a 75.4% market share of global revenues in 2023, driven by increased awareness of the purity and sustainability of algal oil.

The market is projected to grow at a CAGR of 9.6% from 2024 to 2030. Manufacturers are expanding their product lines to include alternative forms, such as powder, to cater to diverse consumer preferences.

Cardiovascular vegan omega-3 supplements accounted for 37.0% of global revenues in 2023. These supplements are commonly used for promoting cardiovascular health, offering significant benefits for maintaining heart function and reducing the risk of heart-related issues.

The market in North America held a 37.1% share of global revenue in 2023, driven primarily by a growing consumer preference for plant-based alternatives and the increasing adoption of vegan and vegetarian lifestyles.

Regional Insights

The market in North America accounted for a share of 37.1% of the global revenue in 2023. The market is primarily driven by a growing consumer preference for plant-based alternatives, in line with the increasing adoption of vegan and vegetarian lifestyles. As more individuals seek sustainable and ethical products, the demand for vegan omega-3 supplements has surged. For example, the rise of plant-based diets among millennials and Gen Z has led to a greater interest in vegan supplements, prompting the industry to expand its product offerings.

U.S. Vegan Omega-3 Supplements Market Trends

The market in the U.S. is projected to grow at a CAGR of 8.8% from 2024 to 2030. The growth of the market is mainly attributed to the increasing consumer awareness of the health benefits associated with omega-3 fatty acids and the shift towards plant-based diets. As more Americans focus on incorporating healthier and sustainable dietary choices into their lifestyles, the demand for vegan omega-3 supplements continues to rise. As per research conducted by Nuseed Nutritional US Inc. in October 2021, 64% of vitamin and mineral supplement consumers preferred plant-based or vegan omega-3 supplements.

Vegan Omega-3 Supplements Market Segmentation

Grand View Research has segmented the global vegan omega-3 supplements market based on source, form, functionality, end-use, distribution channel, and region.

Vegan Omega-3 Supplements Source Outlook (Revenue, USD Million, 2018 - 2030)

Algae

Flaxseed

Chia Seeds

Others

Vegan Omega-3 Supplements Form Outlook (Revenue, USD Million, 2018 - 2030)

Capsules

Liquid

Powder

Others

Vegan Omega-3 Supplements Functionality Outlook (Revenue, USD Million, 2018 - 2030)

Cardiovascular Health

Brain, Nervous System & Mental Health

Eye Diseases

Diabetes

Others

Vegan Omega-3 Supplements End Use Outlook (Revenue, USD Million, 2018 - 2030)

Adults

Geriatric

Pregnant Women

Children

Infants

Vegan Omega-3 Supplements Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

OTC

Prescribed

Vegan Omega-3 Supplements Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Central & South America

Middle East & Africa

List of Key Players in the Vegan Omega-3 Supplements Market

Barlean's Organic Liquid, LLC

i-Health, Inc.

Source Naturals, Inc.

NUTRU

Nordic Naturals

Calgee

NOW Foods

Sunwarrior LLC

Nomolotus, LLC (Truvani)

Doctor’s Best

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/vegan-omega-3-supplements-market-report

[healthcaremarketanalysis]

Exploring the Leading Softgel Capsules Manufacturers: Key Players and Innovations in the Industry

Softgel capsules have become a prominent dosage form in the pharmaceutical, nutraceutical, and cosmetic industries due to their versatility and effectiveness. These capsules provide a highly bioavailable delivery system for a wide range of active ingredients, including vitamins, minerals, herbal extracts, and pharmaceuticals. Behind the success of softgel capsules are leading manufacturers who continually innovate to meet growing market demands. In this blog, we’ll explore the top softgel capsules manufacturers and the key trends shaping this dynamic industry.

1. Catalent Pharma Solutions

Catalent is a global leader in drug delivery technology and is well-known for its expertise in softgel manufacturing. With decades of experience, Catalent provides end-to-end solutions for the development and production of softgel capsules, specializing in nutraceuticals, pharmaceuticals, and over-the-counter (OTC) products. Their patented Vegicaps® technology, a plant-based softgel, addresses the rising demand for vegetarian and vegan-friendly supplements.

Download PDF Brochure

Key Features:

Global manufacturing facilities

Customization of capsule shapes, sizes, and colors

Vegicaps® technology for plant-based softgels

Advanced formulation services

2. Aenova Group

Aenova Group is one of the largest contract manufacturers in the pharmaceutical and healthcare sectors. They offer a comprehensive range of softgel capsule solutions, particularly in the areas of over-the-counter products and dietary supplements. With expertise in gelatin and vegetarian softgels, Aenova ensures high-quality standards and innovative formulations.

Key Features:

Wide range of gelatin and vegetarian softgels

Large-scale production capabilities

Compliance with international quality standards

Research and development for innovative solutions

3. Procaps Group

Procaps Group is a leading integrated CDMO (Contract Development and Manufacturing Organization) that specializes in advanced delivery technologies for softgel capsules. With a focus on innovation, they offer a variety of specialized softgels, such as G-Tek® (gelatin-free) and Unigel® (capsules within capsules) for enhanced product stability and bioavailability.

Key Features:

Gelatin-free G-Tek® softgels for vegetarian products

Unigel® technology for complex formulations

Strong emphasis on sustainability and eco-friendly practices

Expertise in both pharmaceuticals and nutraceuticals

4. Sirio Pharma

Sirio Pharma is a leading contract manufacturer for dietary supplements, with a global presence in the softgel industry. Their state-of-the-art production facilities and cutting-edge technologies allow for the manufacturing of softgel capsules that meet the highest quality standards. Sirio specializes in custom formulations tailored to meet specific client needs in the nutraceutical and pharmaceutical sectors.

Request Sample Pages

Key Features:

Global manufacturing presence

Expertise in custom formulations

Advanced encapsulation technologies

High-volume production capabilities

5. Captek Softgel International

Captek Softgel International is a prominent U.S.-based softgel manufacturer that offers turnkey solutions from formulation to finished product. Specializing in dietary supplements, Captek provides a wide range of softgel options, including gelatin and vegetarian capsules. Their advanced softgel manufacturing capabilities enable them to produce unique and innovative formulations for clients worldwide.

Key Features:

Turnkey manufacturing solutions

Wide variety of softgel formulations

Commitment to quality and product consistency

Extensive experience in the dietary supplement sector

Key Innovations in Softgel Manufacturing

As consumer preferences continue to evolve, manufacturers of softgel capsules are focusing on innovation to address the needs of different markets. Here are some of the top trends and innovations:

Plant-Based Softgels: With a growing demand for vegan and vegetarian supplements, manufacturers are investing in gelatin-free softgel capsules made from plant-based materials such as tapioca and seaweed.

Liquid-Filled Hard Capsules: A relatively new trend is the development of liquid-filled hard capsules, which provide an alternative to traditional softgels while offering similar benefits such as enhanced bioavailability and ease of swallowing.

Sustainability: Environmental concerns are leading to more sustainable manufacturing processes. Many companies are focusing on reducing waste, using eco-friendly packaging, and sourcing sustainable ingredients.

Enhanced Bioavailability: Softgel manufacturers are incorporating advanced technologies to increase the bioavailability of active ingredients, ensuring that consumers receive the full benefits of the supplement or medication.

Conclusion

The softgel capsule industry continues to thrive due to its ability to meet the demands of modern consumers seeking effective, convenient, and innovative dosage forms. Leading manufacturers like Catalent, Aenova, Procaps, Sirio, and Captek are driving the industry forward with their cutting-edge technologies, customized formulations, and commitment to quality. As innovations continue to emerge, softgel capsules are likely to remain a dominant delivery system in the pharmaceutical and nutraceutical markets for years to come.

Whether you are a brand looking for a reliable softgel capsule manufacturer or a consumer interested in the benefits of this dosage form, understanding the key players in the industry can help guide your decisions.

Content Source:

[mpkpr]

Pharmaceutical Softgel Capsules Market Dynamics: Key Drivers and Restraints 2028

"The Pharmaceutical Softgel Capsules Market sector is undergoing rapid transformation, with significant growth and innovations expected by 2028. In-depth market research offers a thorough analysis of market size, share, and emerging trends, providing essential insights into its expansion potential. The report explores market segmentation and definitions, emphasizing key components and growth drivers. Through the use of SWOT and PESTEL analyses, it evaluates the sector’s strengths, weaknesses, opportunities, and threats, while considering political, economic, social, technological, environmental, and legal influences. Expert evaluations of competitor strategies and recent developments shed light on geographical trends and forecast the market’s future direction, creating a solid framework for strategic planning and investment decisions.

Brief Overview of the Pharmaceutical Softgel Capsules Market:

The global Pharmaceutical Softgel Capsules Market is expected to experience substantial growth between 2024 and 2028. Starting from a steady growth rate in 2023, the market is anticipated to accelerate due to increasing strategic initiatives by key market players throughout the forecast period.

Get a Sample PDF of Report - https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pharmaceutical-softgel-capsules-market

Which are the top companies operating in the Pharmaceutical Softgel Capsules Market?

The report profiles noticeable organizations working in the water purifier showcase and the triumphant methodologies received by them. It likewise reveals insights about the share held by each organization and their contribution to the market's extension. This Global Pharmaceutical Softgel Capsules Market report provides the information of the Top Companies in Pharmaceutical Softgel Capsules Market in the market their business strategy, financial situation etc.

Catalent, Inc, Thermo Fisher Scientific Inc., Capsugel, CAPTEK, Eurocaps Ltd., Amway, Sirio Pharma Co., Ltd., Strides Pharma Science Limited, INTERNATIONAL VITAMIN CORPORATION, Weihai Baihe Biology Technological Co., Ltd., Yuwang, Aenova Holding GmbH, Softgel Healthcare, Douglas Laboratories, MEDGEL., Softcaps (Titanium Technologies India Pvt Ltd)., Medikonda Nutrients, Renown Pharmaceuticals Pvt. Ltd., Bolivac Pharmaceutical, Arion Healthcare, Iscon Life Sciences

Report Scope and Market Segmentation

Which are the driving factors of the Pharmaceutical Softgel Capsules Market?

The driving factors of the Pharmaceutical Softgel Capsules Market are multifaceted and crucial for its growth and development. Technological advancements play a significant role by enhancing product efficiency, reducing costs, and introducing innovative features that cater to evolving consumer demands. Rising consumer interest and demand for keyword-related products and services further fuel market expansion. Favorable economic conditions, including increased disposable incomes, enable higher consumer spending, which benefits the market. Supportive regulatory environments, with policies that provide incentives and subsidies, also encourage growth, while globalization opens new opportunities by expanding market reach and international trade.

Pharmaceutical Softgel Capsules Market - Competitive and Segmentation Analysis:

**Segments**

- Based on product type, the pharmaceutical softgel capsules market can be segmented into gelatin softgel capsules and vegetarian softgel capsules. Gelatin softgel capsules have been traditionally popular due to their easy manufacturing process, but in recent years, there has been a growing demand for vegetarian alternatives due to increased awareness about animal-derived products. This segment is expected to witness significant growth as more consumers are seeking plant-based options in their pharmaceutical products.

- On the basis of application, the market can be segmented into vitamins and dietary supplements, cardiovascular therapy, pain management, cough and cold medications, and others. The vitamins and dietary supplements segment is expected to dominate the market during the forecast period due to the rising focus on preventive healthcare and overall wellness. The cardiovascular therapy segment is also expected to show substantial growth as heart-related diseases continue to be a major health concern worldwide.

- Geographically, the global pharmaceutical softgel capsules market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to hold the largest market share due to the presence of major pharmaceutical companies, increasing focus on research and development, and high healthcare expenditure. However, the Asia Pacific region is anticipated to witness the fastest growth due to the expanding pharmaceutical industry, growing population, and rising healthcare awareness in countries like China and India.

**Market Players**

- Some of the key players in the global pharmaceutical softgel capsules market include Catalent, Inc., Capsugel, Aenova Group, EuroCaps Ltd., Sirio Pharma, Patheon, Inc., ProCaps Laboratories, etc. These companies are focusing on innovation, strategic partnerships, and expanding their product portfolios to gain a competitive edge in the market. With increasing investments in research and development and a focus on sustainable manufacturing practices, these market players are poised to capitalize on the growing demand for pharmaceutical softgel capsules.

https://www.databridgemarketresearch.com/reports/global-pharmaceutical-softgel-cIn the evolving landscape of the pharmaceutical softgel capsules market, key market players are continuously adapting to meet the changing demands of consumers and industry trends. One notable trend is the shift towards vegetarian softgel capsules driven by the increasing awareness of animal-derived products among consumers. This transition signifies a growing preference for plant-based alternatives and underscores the importance of catering to diverse dietary requirements in the pharmaceutical sector. Companies like Catalent, Inc., Capsugel, and Aenova Group are strategically positioned to capitalize on this trend by expanding their product portfolios to include vegetarian softgel capsules, thereby enhancing their market competitiveness.

The segmentation of the pharmaceutical softgel capsules market based on application highlights the diverse uses of these capsules in different healthcare sectors. The dominance of the vitamins and dietary supplements segment is attributed to the growing emphasis on preventive healthcare and the expanding consumer base seeking wellness solutions. Furthermore, the cardiovascular therapy segment is poised for significant growth, driven by the rising prevalence of heart-related diseases globally. This presents opportunities for market players to innovate and develop specialized softgel capsules tailored to specific therapeutic applications, thus meeting the evolving needs of healthcare providers and patients.

Geographically, North America emerges as a key market for pharmaceutical softgel capsules, owing to the presence of established pharmaceutical companies, robust research and development activities, and high healthcare expenditure in the region. However, the Asia Pacific region stands out as a hotbed for market growth, fueled by the booming pharmaceutical industry, growing population, and increasing healthcare awareness in countries such as China and India. Market players are actively tapping into this region's potential by expanding their presence, forging strategic partnerships, and leveraging local market insights to drive their growth strategies.

In conclusion, the global pharmaceutical softgel capsules market is witnessing dynamic shifts driven by changing consumer preferences, technological advancements, and evolving healthcare needs. Market players are aligning their business strategies to cater to these trends, with a particular focus on product innovation, sustainability, and market expansion. As the market continues to evolve, companies that can adapt swiftly,**Market Players:** - Catalent, Inc - Thermo Fisher Scientific Inc. - Capsugel - CAPTEK - Eurocaps Ltd. - Amway - Sirio Pharma Co., Ltd. - Strides Pharma Science Limited - INTERNATIONAL VITAMIN CORPORATION - Weihai Baihe Biology Technological Co., Ltd. - Yuwang - Aenova Holding GmbH - Softgel Healthcare - Douglas Laboratories - MEDGEL - Softcaps (Titanium Technologies India Pvt Ltd) - Medikonda Nutrients - Renown Pharmaceuticals Pvt. Ltd. - Bolivac Pharmaceutical - Arion Healthcare - Iscon Life Sciences

**Market Analysis:** In the evolving landscape of the pharmaceutical softgel capsules market, key players such as Catalent, Inc., Thermo Fisher Scientific Inc., and Capsugel are leveraging innovative strategies to adapt to the changing demands of consumers and industry trends. These companies are focusing on expanding their product portfolios to include vegetarian softgel capsules, in line with the shift towards plant-based alternatives driven by increasing consumer awareness. Additionally, market players like Eurocaps Ltd., Amway, and Sirio Pharma Co., Ltd. are actively engaging in strategic partnerships to enhance their market competitiveness.

The pharmaceutical softgel capsules market is witnessing dynamic growth opportunities, with a particular focus on the Asia Pacific region. Companies such as Strides Pharma Science Limited, Weihai Baihe Biology Technological Co., Ltd., and

North America, particularly the United States, will continue to exert significant influence that cannot be overlooked. Any shifts in the United States could impact the development trajectory of the Pharmaceutical Softgel Capsules Market. The North American market is poised for substantial growth over the forecast period. The region benefits from widespread adoption of advanced technologies and the presence of major industry players, creating abundant growth opportunities.

Similarly, Europe plays a crucial role in the global Pharmaceutical Softgel Capsules Market, expected to exhibit impressive growth in CAGR from 2024 to 2028.

Explore Further Details about This Research Pharmaceutical Softgel Capsules Market Report https://www.databridgemarketresearch.com/reports/global-pharmaceutical-softgel-capsules-market

Key Benefits for Industry Participants and Stakeholders: –

Industry drivers, trends, restraints, and opportunities are covered in the study.

Neutral perspective on the Pharmaceutical Softgel Capsules Market scenario

Recent industry growth and new developments

Competitive landscape and strategies of key companies

The Historical, current, and estimated Pharmaceutical Softgel Capsules Market size in terms of value and size

In-depth, comprehensive analysis and forecasting of the Pharmaceutical Softgel Capsules Market

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2024-2028) of the following regions are covered in Chapters

The countries covered in the Pharmaceutical Softgel Capsules Market report are U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, and Rest of the Middle East and Africa

Detailed TOC of Pharmaceutical Softgel Capsules Market Insights and Forecast to 2028

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Pharmaceutical Softgel Capsules Market Landscape

Part 05: Pipeline Analysis

Part 06: Pharmaceutical Softgel Capsules Market Sizing

Part 07: Five Forces Analysis

Part 08: Pharmaceutical Softgel Capsules Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Pharmaceutical Softgel Capsules Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Browse More Reports:

North America Fatty Acids Market – Industry Trends and Forecast Ad Server Advertising Software Market – Industry Trends and Forecast Aspirin Market – Industry Trends and Forecast Filter Paper Market – Industry Trends and Forecast Aquafeed Mycotoxin Binders and Modifiers Market – Industry Trends and Forecast Automated Feeding Systems for Poultry Market – Industry Trends and Forecast Data Centre Open Frame Rack Market – Industry Trends and Forecast Portable Logic Analyzer Market – Industry Trends and Forecast Suspended Particle Devices (SPD) for Smart Window Market – Industry Trends and Forecast Disposable Protective Clothing Market – Industry Trends and Forecast Foam Tray Market – Industry Trends and Forecast Soybean Oil-Based Lubricant Market – Industry Trends and Forecast Wind Turbine Operations and Maintenance Market – Industry Trends and Forecast Security System at Workplace Market – Industry Trends and Forecast Plastic-Based Egg Market – Industry Trends and Forecast

Data Bridge Market Research:

Today's trends are a great way to predict future events!

Data Bridge Market Research is a market research and consulting company that stands out for its innovative and distinctive approach, as well as its unmatched resilience and integrated methods. We are dedicated to identifying the best market opportunities, and providing insightful information that will help your business thrive in the marketplace. Data Bridge offers tailored solutions to complex business challenges. This facilitates a smooth decision-making process. Data Bridge was founded in Pune in 2015. It is the product of deep wisdom and experience.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC: +653 1251 978

Email:- corporatesales@databridgemarketresearch.com "